GENOCEA BIOSCIENCES INC's ticker is GNCA and the CUSIP is 372427401. A total of 34 filers reported holding GENOCEA BIOSCIENCES INC in Q2 2020. The put-call ratio across all filers is 0.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $716,000 | +148.6% | 312,666 | +149.5% | 0.11% | +84.5% |
Q2 2020 | $288,000 | -62.0% | 125,312 | -71.5% | 0.06% | -81.6% |
Q1 2020 | $757,000 | -32.0% | 440,274 | -18.2% | 0.32% | +1.9% |
Q4 2019 | $1,114,000 | -19.5% | 538,359 | +12.8% | 0.31% | -58.6% |
Q3 2019 | $1,384,000 | -28.5% | 477,351 | -3.4% | 0.75% | -69.4% |
Q2 2019 | $1,937,000 | – | 494,175 | – | 2.44% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NEA Management Company, LLC | 7,225,676 | $12,428,000 | 0.65% |
FNY Investment Advisers, LLC | 300,000 | $516,000 | 0.39% |
DAFNA Capital Management LLC | 542,564 | $933,000 | 0.39% |
Polaris Venture Management Co. V, L.L.C. | 246,078 | $423,000 | 0.38% |
BVF INC/IL | 2,100,305 | $3,613,000 | 0.34% |
SABBY MANAGEMENT, LLC | 440,274 | $757,000 | 0.32% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 711,552 | $1,224,000 | 0.22% |
Endurant Capital Management LP | 264,307 | $455,000 | 0.21% |
Johnson & Johnson Innovation - JJDC, Inc. | 143,964 | $248,000 | 0.14% |
Alyeska Investment Group, L.P. | 1,497,500 | $2,576,000 | 0.05% |